Patent classifications
C
CHEMISTRY; METALLURGY
Load children
C07
ORGANIC CHEMISTRY
Load children
C07C
ACYCLIC OR CARBOCYCLIC COMPOUNDS
Load children
C07C233/64
having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
Load children Filter patents View analytics View as hierarchy Open in page
C07C233/77
having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
Load children Filter patents View analytics View as hierarchy Open in page

C07C233/77

Compound, core-shell dye, photosensitive resin composition including the same, and color filter
12110262 · 2024-10-08 · ·

A compound represented by a specific chemical formula, a core including the compound represented by the specific chemical formula, and a core-shell dye including a shell surrounding the core, a photosensitive resin composition including the compound represented by the specific chemical formula, and a color filter manufactured using the photosensitive resin composition are disclosed.

Compound, core-shell dye, photosensitive resin composition including the same, and color filter
12110262 · 2024-10-08 · ·

A compound represented by a specific chemical formula, a core including the compound represented by the specific chemical formula, and a core-shell dye including a shell surrounding the core, a photosensitive resin composition including the compound represented by the specific chemical formula, and a color filter manufactured using the photosensitive resin composition are disclosed.

HDAC INHIBITOR COMPOUNDS AND METHODS OF TREATMENT
20170174619 · 2017-06-22 ·

The instant invention describes hydrazide-containing compounds having therapeutic activity, and methods of treating disorders such as cancer, tumors and cell proliferation related disorders, or affect cell differentiation, dedifferentiation or transdifferentiation.

HDAC INHIBITOR COMPOUNDS AND METHODS OF TREATMENT
20170174619 · 2017-06-22 ·

The instant invention describes hydrazide-containing compounds having therapeutic activity, and methods of treating disorders such as cancer, tumors and cell proliferation related disorders, or affect cell differentiation, dedifferentiation or transdifferentiation.